Christine Bestvina to Brain Neoplasms
This is a "connection" page, showing publications Christine Bestvina has written about Brain Neoplasms.
Connection Strength
0.131
-
Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice. Clin Cancer Res. 2022 03 15; 28(6):1117-1126.
Score: 0.131